These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2164430)

  • 1. Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein.
    Wynick D; Ratcliffe WA; Heath DA; Ball S; Barnard M; Bloom SR
    BMJ; 1990 May; 300(6735):1314-5. PubMed ID: 2164430
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of a pancreatic tumour secreting parathyroid hormone related protein.
    Dodwell D; Gurney H; Scarffe H; Abbas S
    BMJ; 1990 Jun; 300(6740):1653. PubMed ID: 2372652
    [No Abstract]   [Full Text] [Related]  

  • 3. Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas.
    Mitlak BH; Hutchison JS; Kaufman SD; Nussbaum SR
    Horm Metab Res; 1991 Jul; 23(7):344-6. PubMed ID: 1663481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intractable hypercalcemia due to a metastatic carcinoid secreting parathyroid hormone-related peptide and interleukin-6: response to octreotide.
    Barhoum M; Hutchins L; Fonseca VA
    Am J Med Sci; 1999 Sep; 318(3):203-5. PubMed ID: 10487414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant islet cell tumor associated with hypercalcemia.
    Mao C; Carter P; Schaefer P; Zhu L; Dominguez JM; Hanson DJ; Appert HE; Kim K; Howard JM
    Surgery; 1995 Jan; 117(1):37-40. PubMed ID: 7809834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
    Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogue: use in the treatment of vipoma with hypercalcemia.
    Venkatesh S; Vassilopoulou-Sellin R; Samaan NA
    Am J Med; 1989 Sep; 87(3):356-7. PubMed ID: 2549791
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
    Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
    Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?
    Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR
    Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrotoxic and cytoproliferative effects of streptozotocin: report of a patient with multiple hormone-secreting islet cell carcinoma.
    Myerowitz RL; Sartiano GP; Cavallo T
    Cancer; 1976 Oct; 38(4):1550-5. PubMed ID: 186169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide--a synthetic somatostatin.
    Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
    [No Abstract]   [Full Text] [Related]  

  • 12. Case report: life-threatening hypercalcaemia secondary to pancreatic tumour secreting parathyroid hormone-related protein--successful control by hepatic arterial embolization.
    Tarver DS; Birch SJ
    Clin Radiol; 1992 Sep; 46(3):204-5. PubMed ID: 1395428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
    Ligorria C; Montaña E; Virgili N
    Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance of metastatic pancreatic endocrine tumours after long-term treatment with the somatostatin analogue octreotide (SMS 201-995).
    Wynick D; Anderson JV; Williams SJ; Bloom SR
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):385-8. PubMed ID: 2557179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
    Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R
    Digestion; 1989; 42(2):116-20. PubMed ID: 2548911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical applications of octreotide in gastro-entero-pancreatic (GEP) tumors].
    Arnold R; Neuhaus C; Trautmann M
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():22-8. PubMed ID: 1980774
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-acting somatostatin analogues in pancreatic islet cell carcinoma.
    Souquet JC
    Horm Res; 1989; 32(1-3):74-6. PubMed ID: 2559020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conservative treatment of pancreatic insulin-secreting insulinoma].
    Muszyński J
    Pol Arch Med Wewn; 1978 Mar; 59(3):361-6. PubMed ID: 209417
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic islet cell carcinoma with hypercalcemia: complete remission 5 years after surgical excision and chemotherapy.
    Bresler L; Boissel P; Conroy T; Grosdidier J
    Am J Gastroenterol; 1991 May; 86(5):635-8. PubMed ID: 1851392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin analogues in the management of benign insulinomas.
    Laron Z
    Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.